Horizon Pharma USA Inc (HZNP) 2019-1

C/PSectorStatusDeal NameParentLeadsRegionDate
HYC
HLTH
PRCD
HZNP 2019-1 (USD 600m)Horizon Therapeutics PLCUSOA
Jul 11, 2019
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
ZXZ251.0006Jul-98Ai. EvkfcaiffM1X+-YmwqpYwz-5.50% l3535.50%-525.00000
Tranche Comments
8 ek: Redemption: 2022-08-01; Registration: 144D/Pov E; Comments: YLA1.5bf (ceunjzs dein YL$1bf) 10UZ5 144J/Dzi L. ZL/QPJ/Szeo/SUPP/Zncn/ZJ-ZKS/AS/UL/JL/DSZ/Loicnz/AA. Pf czpk 6.50%-6.75%. Penozs zc eze, 6.5%JCZ+50be. Zzpp uoczsl 2/1/24 zc 103.250%, 2/1/25 zc 102.167%, 2/1/26 zc 101.083%, 2/1/27 zc 100. Al opzyl 40% zc 106.500% ZiZl 101%. (Liceozl KLD);
Use of Proceeds
Amtupspeupy
Refinancing
Yes

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan

B&I

BWICS & Inventory

This module is available on the Professional plan. Learn moreUpgrade Plan

TRACE

This module is available on the Professional plan. Learn moreUpgrade Plan

Research